Sara
Labiano Almiñana
Investigadora
Centro Nacional de Investigaciones Cardiovasculares Carlos III
Madrid, EspañaPublicacions en col·laboració amb investigadors/es de Centro Nacional de Investigaciones Cardiovasculares Carlos III (4)
2018
-
Intratumoral immunotherapy with XCL1 and sFlt3L encoded in recombinant semliki forest virus–derived vectors fosters dendritic cell–mediated t-cell cross-priming
Cancer Research, Vol. 78, Núm. 23, pp. 6643-6654
-
Mitochondrial morphological and functional reprogramming following CD137 (4-1BB) Costimulation
Cancer Immunology Research, Vol. 6, Núm. 7, pp. 798-811
2017
-
CD69 is a direct HIF-1α target gene in hypoxia as a mechanism enhancing expression on tumor-infiltrating T lymphocytes
OncoImmunology, Vol. 6, Núm. 4
2016
-
Cancer immunotherapy with immunomodulatory anti-CD137 and anti–PD-1 monoclonal antibodies requires BATF3-dependent dendritic cells
Cancer Discovery, Vol. 6, Núm. 1, pp. 71-79